Regencell Bioscience
4 hedge funds and large institutions have $18.9K invested in Regencell Bioscience in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$5K |
| 2 |
2
Morgan Stanley
New York
|
$7.69K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$26 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $7.69K | +$414 | +608 | +6% |
|
2
BlackRock
New York
| $6.16K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $5K | +$5K | +7,600 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $26 | -$17.4K | -25,384 | -100% |
|